Neurology
News
Guillain-Barré incidence rose with Zika across Americas
News
FDA: New labeling warns against combining opioids, benzodiazepines
Prescription opioid pain or cough medicines and benzodiazepines will now carry the strongest available warning regarding serious side effects and...
Conference Coverage
VIDEO: Smell test reflects brain pathologies, risk of Alzheimer’s progression
Low scores on the UPSIT olfaction test are related to both brain pathology and progression to dementia.
News
MRI-guided thalamotomy significantly reduces hand tremors
Key clinical point: The severity of hand tremors in patients with essential tremor can be significantly reduced via use of MRI-guided focused...
News
Studies suggest moving SNAP outside of Alzheimer’s framework
Key clinical point: Two studies from JAMA Neurology raise doubts about whether suspected non-Alzheimer’s pathophysiology truly belongs on the...
Commentary
Myth of the Month: Vaccinations in patients with Guillain-Barré syndrome
Is there good evidence for patients with a history of Guillain-Barré syndrome to avoid influenza vaccines or vaccinations in general?
News
Cognitive impairment predicts worsening multiple sclerosis
News
Thymectomy improves clinical outcomes for myasthenia gravis
Thymectomy improved 3-year clinical outcomes and was superior to medical therapy for mild to severe nonthymomatous myasthenia gravis.
Conference Coverage
For neuropathic pain, marijuana yields modest benefits
Conference Coverage
Retinal nerve fiber layer thinning predicts cognitive decline
Key clinical point: Thinning of the retinal nerve fiber layer was associated with poorer cognitive performance and predicted cognitive decline as...
Conference Coverage
Early Alzheimer’s treatment decreases both costs and mortality
Key clinical point: Alzheimer’s patients who get early medical treatment have less risk of dying and incur lower health care costs. Major finding...